|Application ||WB, E|
|Calculated MW||28228 Da|
|Antigen Region||222-251 aa|
|Other Names||Kunitz-type protease inhibitor 2, Hepatocyte growth factor activator inhibitor type 2, HAI-2, Placental bikunin, SPINT2, HAI2, KOP|
|Target/Specificity||This SPINT2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 222-251 amino acids from the C-terminal region of human SPINT2.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||SPINT2 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Inhibitor of HGF activator. Also inhibits plasmin, plasma and tissue kallikrein, and factor XIa.|
|Cellular Location||Membrane; Single-pass type I membrane protein|
|Tissue Location||Expressed in placenta, kidney, pancreas, prostate, testis, thymus, and trachea|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
This gene encodes a transmembrane protein with two extracellular Kunitz domains that inhibits a variety of serine proteases. The protein inhibits HGF activator which prevents the formation of active hepatocyte growth factor. This gene is a putative tumor suppressor, and mutations in this gene result in congenital sodium diarrhea. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq].
Dong, W., et al. Int. J. Cancer 127(7):1526-1534(2010)
Bergum, C., et al. Prostate 70(13):1422-1428(2010)
Sivagnanam, M., et al. Clin. Dysmorphol. 19 (1), 48 (2010) :
Yamauchi, M., et al. Biol. Chem. 383(12):1953-1957(2002)
Itoh, H., et al. Eur. J. Biochem. 267(11):3351-3359(2000)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.